Grand Hyatt Hotel, New York City 2012 | November 28-30

32
INNOvATOR PREsENTATION
INNOvATOR PREsENTATION
11:15 AM – 11:40 AM ALViN/CArNEgiE
NCI SBIR Investor Forum
The National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Investor Forum brings together
government and industry to accelerate the commercialization of innovative cancer-related technologies.
The Investor Forum advances government-funded innovations toward the patient by connecting investors
with companies validated through NCI SBIR/Small Business Technology Transfer funding and forum
selection. The 2012 forum enabled 18 selected companies to present to more than 150 potential investors
and was the venue for more than 100 one-on-one meetings. Seven of the 14 presenting companies at the
2010 forum have secured deals worth $235 million from relationships established at the event. The forums
demonstrate the transformative opportunity for the government to facilitate follow-on investments in
funded technologies.
Presented by:
todd haiM, Program Director, NCI SBIR Development Center
11:15 AM – 11:40 AM UriS/JULLiArd
New York Genome Center: Collaboration for Life
Genomics will fundamentally change healthcare. It impacts the entire disease detection, diagnosis,
treatment, and prevention spectrum. The use of sequencing data, coupled with the power of bioinformatics,
will accelerate drug development, greatly enhance the efficiency of R&D expenditures, and enable physicians
to provide the right treatments, to the right targeted patient populations, at the right price, in the right time.
The New York Genome Center has harnessed the power of 11 major academic medical and research centers,
along with world-class bioscience and technology companies, to create an exciting new research and
innovation paradigm that will transform science and healthcare.
Presented by:
nancy J. kelley, Founding Executive Director, New York Genome Center